header image

MicroDose Therapeutx To Become Wholly Owned Subsidiary of Teva Pharmaceutical Industries Ltd

Read More

changing the way the world takes its medicine

Launched in 1998 with the introduction of its revolutionary electronic dry powder inhaler, privately held MicroDose Therapeutx (MDTx) focuses on the creation of products utilizing its proprietary drug delivery technologies. The name change to MicroDose Therapeutx reflects the expansion of MDTx’s business, its capabilities and its products.

delivery platforms

Read about our three core
technology platforms spanning
pulmonary, solid oral dosage,
and transdermal drug delivery.

read more…

product pipeline

MDTx is creating industry
leading products utilizing
our revolutionary inhalation
and oral dosage technologies.

read more…


MicroDose Defense Products
develops inhaled medical products meeting unmet needs
for the defense organizations.

read more…